CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Jacksonville, Florida, United States and 166 other locations
CAR T-cell therapy, in patients with ROR1+ relapsed or refractory triple negative breast cancer (TNBC), non-small...
Phase 1
Jacksonville, Florida, United States and 17 other locations
This is a Phase III, randomised, open-label, 3-arm, multicentre, international study assessing the efficacy and safety of Dato-DXd with or without du...
Phase 3
Jacksonville, Florida, United States and 288 other locations
cancers.* Part D will find out if and how much SGN-B7H4V can be given with pembrolizumab.* Part E will use the amount found in Part D to fi ...
Phase 1
Jacksonville, Florida, United States and 18 other locations
including metastatic colorectal cancer (mCRC) patients....
Phase 1
Fleming Island, Florida, United States and 38 other locations
The primary purpose of this study is to assess the safety and tolerability of AB598 when taken alone, and in combination with zimberelimab and standa...
Phase 1
Jacksonville, Florida, United States and 13 other locations
The objective of this study is to assess safety and efficacy of CAB-ROR2-ADC in solid tumors...
Phase 1, Phase 2
Fleming Island, Florida, United States and 58 other locations
with standard of care treatment (docetaxel) or another antibody cancer drug, pembrolizumab (with or without chemotherapy), for treatment of ...
Phase 1, Phase 2
Jacksonville, Florida, United States and 56 other locations
-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), end...
Phase 1, Phase 2
Jacksonville, Florida, United States and 123 other locations
systemic therapy works in treating patients with HER2 positive or triple negative breast cancer when image-guided...
Jacksonville, Florida, United States and 7 other locations
Clinical trials
Research sites
Resources
Legal